NCT03422640View on ClinicalTrials.gov

Trial Evaluating the Efficacy of Apremilast for the Treatment of Frontal Fibrosing Alopecia

PHASE4UnknownINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

July 12, 2018

Primary Completion Date

January 31, 2019

Study Completion Date

January 31, 2019

Conditions

Frontal Fibrosing Alopecia

Interventions

DRUG

Apremilast

Open label treatment with apremilast

Trial Locations (1)

98004

RECRUITING

Bellevue Dermatology, Bellevue

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Celgene

INDUSTRY

lead

Bellevue Dermatology

OTHER

NCT03422640 - Trial Evaluating the Efficacy of Apremilast for the Treatment of Frontal Fibrosing Alopecia | Biotech Hunter | Biotech Hunter